Neogen Chemicals Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a consolidated profit for the period of ₹28.75 crore for the full financial year. Additionally, the Board has recommended a final dividend of ₹1 per equity share for FY 2025-26, subject to shareholder approval at the upcoming 37th Annual General Meeting.
Financial Performance Highlights
For the financial year ended March 31, 2026, Neogen Chemicals achieved a consolidated revenue from operations of ₹861.96 crore. The consolidated profit for the year stood at ₹28.75 crore. For the final quarter (Q4) ending March 31, 2026, the company reported a consolidated profit of ₹11.39 crore, demonstrating sequential growth from the previous quarter.
Strategic Project Updates
The company provided critical updates regarding its wholly owned subsidiary, Neogen Ionics Limited. Revised timelines for major projects indicate the Dahej Phase 1 project is now expected to be completed by February 2027, with a projected cost of ₹428 crore. The Pakhajan Phase 2 project, with an estimated cost of ₹1,367 crore, is slated for completion by March 2027. These adjustments are attributed to design optimizations and a shift toward Japanese technology to enhance localization and reduce import dependence.
Shareholder Returns and Governance
The Board of Directors has recommended a final dividend of ₹1 per equity share for the fiscal year 2025-26. This dividend payout is subject to approval by shareholders at the company’s 37th Annual General Meeting. Furthermore, the company has successfully completed the allotment of 10,00,000 equity shares to a promoter group entity on a preferential basis, raising ₹161 crore in capital, which was finalized in April 2026.
Fire Incident and Insurance Update
The company provided a status update on the fire incident at its Dahej SEZ plant which occurred in March 2025. As of March 31, 2026, the balance insurance claim receivable is ₹188.96 crore. Management continues to work closely with the insurance provider and considers the outstanding balance to be fully recoverable, maintaining an un-modified audit opinion regarding this matter.
Source: BSE
